Therapeutic Class Overview: Treating Refractory Hematological Malignancies - 1 views
-
Olivia Lopez on 10 Apr 14The report provides an overview of the approved therapies for rrmm, ndmm, aml, mds, unmet need and limitations of the current soc for relapsed and refractory pts.